The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Breast Imaging With Positron Emission Tomography and Fluorine-18 Fluorodeoxyglucose: Use and Limitations
Abstract
PURPOSE: To evaluate the diagnostic value of positron emission tomography (PET) using fluorine-18 fluorodeoxyglucose (FDG) for the diagnosis of primary breast cancer. PATIENTS AND METHODS: Preoperatively, 144 patients with masses suggestive of breast cancer underwent PET imaging of the breast. To identify breast cancer by increased metabolic activity, parametric FDG-PET images were analyzed for increased tracer uptake applying conventional image reading (CIR) and sensitive image reading (SIR). One hundred eighty-five breast tumors were evaluated by histology, revealing 132 breast carcinomas and 53 benign masses. RESULTS: Breast carcinomas were identified with an overall sensitivity of 64.4% (CIR) and 80.3% (SIR). The increase in sensitivity (SIR) resulted in a noticeable decrease in specificity, from 94.3% (CIR) to 75.5% (SIR). At stage pT1, only 30 (68.2%) of 44 breast carcinomas were detected, compared with 57 (91.9%) of 62 at stage pT2. A higher percentage of invasive lobular carcinomas were false-negative (65.2%) compared with invasive ductal carcinomas (23.7%). Nevertheless, positive PET scans provided a high positive-predictive value (96.6%) for breast cancer. CONCLUSION: Partial volume effects and varying metabolic activity (dependent on tumor type) seem to represent the most significant limitations for the routine diagnostic application of PET. The number of invasive procedures is therefore unlikely to be significantly reduced by PET imaging in patients presenting with abnormal mammography. However, the high positive-predictive value, resulting from the increased metabolic activity of malignant tissue, may be used with carefully selected subsets of patients as well as to determine the extent of disease or to assess therapy response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
Carter, C. L., Allen, C., & Henson, D. E. (1989) · Cancer · doi:10.1002/1097-0142(19890101)63:1<181::aid-cncr2820630129>3.0.co;2-h · Cited by 2,288
Solid breast nodules: use of sonography to distinguish between benign and malignant lesions.
Stavros, A. T., Thickman, D., Rapp, C. L., Dennis, M. A., Parker, S. H., & Sisney, G. A. (1995) · Radiology · doi:10.1148/radiology.196.1.7784555 · Cited by 1,780
Hamacher, K., Coenen, H. H., & Stöcklin, G. (1986) · PubMed · Cited by 1,351
Quantitation in Positron Emission Computed Tomography: 1. Effect of Object Size
Hoffman, E. J., Huang, S.-C., & Phelps, M. E. (1979) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-197906000-00001 · Cited by 1,143
Analysis of cancers missed at screening mammography.
Bird, R. E., Wallace, T. W., & Yankaskas, B. C. (1992) · Radiology · doi:10.1148/radiology.184.3.1509041 · Cited by 820
WARBURN, O., & DICKENS, F. (1931) · The American Journal of the Medical Sciences · doi:10.1097/00000441-193107000-00022 · Cited by 808
Report of the International Workshop on Screening for Breast Cancer
Fletcher, S. W., Black, W., Harris, R., Rimer, B. K., & Shapiro, S. (1993) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/85.20.1644 · Cited by 792
Wahl, R. L., Zasadny, K., Helvie, M., Hutchins, G. D., Weber, B., & Cody, R. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.11.2101 · Cited by 605
Schelling, M., Avril, N., Nährig, J., Kuhn, W., Römer, W., Sattler, D., Werner, M., Dose, J., Jänicke, F., Graeff, H., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1689 · Cited by 522
Self-citationSom, P., Atkins, H. L., Bandoypadhyay, D., Fowler, J. S., MacGregor, R. R., Matsui, K., Oster, Z. H., Sacker, D. F., Shiue, C. Y., Turner, H., et al. (1980) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198012000-00045 · Cited by 504
Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose
Rigo, P., Paulus, P., Kaschten, B. J., Hustinx, R., Bury, T., Jerusalem, G., Benoit, T., & Foidart-Willems, J. (1996) · European Journal of Nuclear Medicine · doi:10.1007/bf01249629 · Cited by 501
Wahl, R. L., Cody, R. L., Hutchins, G. D., & Mudgett, E. E. (1991) · Radiology · doi:10.1148/radiology.179.3.2027989 · Cited by 431
The positive predictive value of mammography.
Kopans, D. B. (1992) · American Journal of Roentgenology · doi:10.2214/ajr.158.3.1310825 · Cited by 413
Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET.
Adler, L. P., Crowe, J. P., al-Kaisi, N. K., & Sunshine, J. L. (1993) · Radiology · doi:10.1148/radiology.187.3.8497624 · Cited by 372
Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis.
Lewis, P. J., & Salama, A. (1994) · PubMed · Cited by 287
Moon, D. H., Maddahi, J., Silverman, D. H. S., Glaspy, J. A., Phelps, M. E., & Hoh, C. K. (1998) · PubMed · Cited by 274
Jansson, T., Westlin, J. E., Ahlström, H., Lilja, A., Långström, B., & Bergh, J. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.6.1470 · Cited by 257
Avril, N., Dose, J., Jänicke, F., Bense, S., Ziegler, S., Laubenbacher, C., Römer, W., Pache, H., Herz, M., Allgayer, B., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.6.1848 · Cited by 242
Self-citationNieweg, O. E., Kim, E. E., Wong, W.-H., Broussard, W. F., Singletary, S. E., Hortobagyi, G. N., & Tilbury, R. S. (1993) · Cancer · doi:10.1002/1097-0142(19930615)71:12<3920::aid-cncr2820711220>3.0.co;2-n · Cited by 223
Avril, N., Dose, J., Janicke, F., Ziegler, S., Romer, W., Weber, W., Herz, M., Nathrath, W., Graeff, H., & Schwaiger, M. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.17.1204 · Cited by 213
Self-citationBassa, P., Kim, E. E., INOUE, T., Wong, F. C., Korkmaz, M., Yang, D. J., Wong, W., Hicks, K., Buzdar, A. U., & Podoloff, D. A. (1996) · PubMed · Cited by 210
TSE, N. Y., HOH, C. K., HAWKINS, R. A., ZINNER, M. J., DAHLBOM, M., CHOI, Y., MADDAHI, J., BRUNICARDI, F. C., PHELPS, M. E., & GLASPY, J. A. (1992) · Annals of Surgery · doi:10.1097/00000658-199207000-00005 · Cited by 180
High [18F]-Fluorodeoxyglucose Uptake in Abdominal Abscesses: A PET Study
Tahara, T., Ichiya, Y., Kuwabara, Y., Otsuka, M., Miyake, Y., Gunasekera, R., & Masuda, K. (1989) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198909000-00014 · Cited by 173
Breast imaging with fluorine-18-FDG PET: quantitative image analysis.
Avril, N. E., Bense, S., Ziegler, S. I., Dose, J., Weber, W., Laubenbacher, C., Römer, W., Jänicke, F., & Schwaiger, M. (1997) · PubMed · Cited by 171
Self-citationEvaluation of a Palpable Breast Mass
Desforges, J. F., & Donegan, W. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209243271307 · Cited by 151
Relevance of Positron Emission Tomography (PET) in Oncology
Weber, W., Avril, N. E., & Schwaiger, M. (1999) · Strahlentherapie und Onkologie · doi:10.1007/s000660050022 · Cited by 148
Self-citationScheidhauer, K., Scharl, A. J., Pietrzyk, U., Wagner, R., G�hring, U.-J., Schomäcker, K., & Schicha, H. (1996) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00834522 · Cited by 139
Bender, H., Kirst, J., PALMEDO, H., Schomburg, A., Wagner, U. A. G., Ruhlmann, J., & Hj, B. (1997) · PubMed · Cited by 135
Biopsy of occult breast lesions. Analysis of 1261 abnormalities
Meyer, J. E. (1990) · JAMA · doi:10.1001/jama.263.17.2341 · Cited by 131
Torizuka, T., Zasadny, K. R., Recker, B., & Wahl, R. L. (1998) · Radiology · doi:10.1148/radiology.207.3.9609902 · Cited by 81
Tumor oxygenation correlates with molecular growth determinants in breast cancer
Hohenberger, P., Felgner, C., Haensch, W., & Schlag, P. M. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1005921513083 · Cited by 66
MAMMOGRAPHY SCREENING AND THE CONTROVERSY CONCERNING WOMEN AGED 40 TO 49
Kopans, D. B. (1995) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(22)00657-1 · Cited by 30
Cited by
Fluorine in medicinal chemistry: A review of anti-cancer agents
Isanbor, C., & O’Hagan, D. (2006) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2006.01.011 · Cited by 1,120
Clinical Applications of PET in Oncology
Rohren, E. M., Turkington, T. G., & Coleman, R. E. (2004) · Radiology · doi:10.1148/radiol.2312021185 · Cited by 859
Kuhl, C. (2007) · Radiology · doi:10.1148/radiol.2442051620 · Cited by 778
(2004) · PubMed · Cited by 653
Bos, R., van der Hoeven, J. J. M., van der Wall, E., van der Groep, P., van Diest, P. J., Comans, E. F. I., Joshi, U., Semenza, G. L., Hoekstra, O. S., Lammertsma, A. A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.379 · Cited by 591
Metadata
- Authors
- Avril, N., Rosé, C. A., Schelling, M., Dose, J., Kuhn, W., Bense, S., Weber, W., Ziegler, S., Graeff, H., & Schwaiger, M.
- Venue
- Journal of Clinical Oncology
- Published
- 2000-10-20
- Volume
- 18
- Issue
- 20
- Pages
- 3495-3502
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1946385338
- Cited by
- 557
- References
- 33
- FWCI
- 12.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.